

Exploring Rapamycin, Longevity and Healthspan with Dr. Matt Kaeberlein
Feb 9, 2024
Dr. Matt Kaeberlein, CEO of OptiSpan and co-director of the Dog Aging Project, discusses the potential of rapamycin for longevity and healthspan. He explains the biological mechanisms, optimal dosing, and effects on the immune system. They also explore aging clocks, biomarkers, and the significance of the microbiome in aging research. Visit OptiSpan.life for more information.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
The Potential of Rapamycin for Anti-Aging
02:29 • 16min
Rapamycin and Food Sensitivities
18:10 • 18min
Biological Aging Clocks: Research vs. Direct-to-Consumer
36:03 • 6min
Challenges in Publishing Research and Validating Epigenetic Tests
42:23 • 15min
Exploring the Role of the Microbiome in Health and Aging
57:13 • 3min
Challenges and Opportunities for Improving Health Span and Lifespan
01:00:23 • 3min